SYM FINANCIAL Corp Makes New Investment in Lam Research Co. (NASDAQ:LRCX)

SYM FINANCIAL Corp purchased a new position in Lam Research Co. (NASDAQ:LRCX) in the fourth quarter, Holdings Channel reports. The fund purchased 12,080 shares of the semiconductor company’s stock, valued at approximately $873,000.

Several other large investors also recently made changes to their positions in LRCX. Migdal Insurance & Financial Holdings Ltd. boosted its position in Lam Research by 2,400.0% during the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 200 shares of the semiconductor company’s stock worth $163,000 after purchasing an additional 192 shares during the period. Sunflower Bank N.A. bought a new stake in shares of Lam Research during the 3rd quarter worth $202,000. Insight Wealth Partners LLC acquired a new position in Lam Research in the 3rd quarter valued at $202,000. B&L Asset Management LLC bought a new position in Lam Research in the 3rd quarter worth $204,000. Finally, CWC Advisors LLC. acquired a new position in Lam Research during the 3rd quarter worth $220,000. Institutional investors own 84.61% of the company’s stock.

Lam Research Stock Up 0.4 %

Shares of NASDAQ:LRCX opened at $81.05 on Friday. The company’s fifty day moving average is $76.05 and its 200-day moving average is $78.95. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.74 and a current ratio of 2.53. Lam Research Co. has a 52 week low of $68.87 and a 52 week high of $113.00. The company has a market capitalization of $104.29 billion, a PE ratio of 24.62, a P/E/G ratio of 1.38 and a beta of 1.45.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Lam Research had a net margin of 26.49% and a return on equity of 52.58%. Equities research analysts predict that Lam Research Co. will post 3.51 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 8th. Investors of record on Wednesday, December 11th were issued a dividend of $0.23 per share. The ex-dividend date of this dividend was Wednesday, December 11th. This represents a $0.92 dividend on an annualized basis and a yield of 1.14%. Lam Research’s dividend payout ratio is 27.95%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on LRCX. Wells Fargo & Company raised their price target on Lam Research from $82.00 to $85.00 and gave the company an “equal weight” rating in a research report on Thursday. Mizuho dropped their price target on Lam Research from $95.00 to $90.00 and set an “outperform” rating on the stock in a research report on Friday, January 10th. The Goldman Sachs Group reduced their price objective on Lam Research from $96.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, January 10th. Cantor Fitzgerald raised shares of Lam Research from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $95.00 to $100.00 in a research report on Thursday. Finally, Morgan Stanley increased their price target on shares of Lam Research from $76.00 to $78.00 and gave the company an “equal weight” rating in a report on Thursday, December 5th. Seven research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and an average price target of $95.72.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.